 Jamaluddin Moloo
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 3 | 2022 | 1727 | 0.270 |
Why?
| | Marketing | 1 | 2003 | 24 | 0.220 |
Why?
| | Ethics, Medical | 1 | 2003 | 70 | 0.220 |
Why?
| | Drug Industry | 1 | 2003 | 104 | 0.200 |
Why?
| | Tomography, X-Ray Computed | 2 | 2009 | 2269 | 0.200 |
Why?
| | Coronary Stenosis | 1 | 2022 | 39 | 0.200 |
Why?
| | Plaque, Atherosclerotic | 1 | 2022 | 44 | 0.190 |
Why?
| | Coronary Disease | 3 | 2012 | 347 | 0.160 |
Why?
| | Animals, Domestic | 1 | 1998 | 11 | 0.160 |
Why?
| | Chest Pain | 3 | 2022 | 80 | 0.150 |
Why?
| | Social Class | 1 | 1998 | 204 | 0.140 |
Why?
| | Mortality | 1 | 1998 | 288 | 0.140 |
Why?
| | Attitude of Health Personnel | 1 | 2003 | 977 | 0.140 |
Why?
| | Coronary Artery Disease | 1 | 2022 | 607 | 0.130 |
Why?
| | Physicians | 1 | 2003 | 772 | 0.130 |
Why?
| | Acute Coronary Syndrome | 2 | 2009 | 254 | 0.120 |
Why?
| | Hypertension | 2 | 2012 | 1059 | 0.120 |
Why?
| | Health Status | 1 | 1998 | 723 | 0.110 |
Why?
| | Coronary Angiography | 2 | 2022 | 304 | 0.110 |
Why?
| | Sodium Chloride Symporter Inhibitors | 1 | 2012 | 9 | 0.100 |
Why?
| | Chlorthalidone | 2 | 2012 | 5 | 0.090 |
Why?
| | Contraindications | 1 | 2008 | 85 | 0.080 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2012 | 486 | 0.070 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 98 | 0.070 |
Why?
| | Triage | 1 | 2009 | 192 | 0.070 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 222 | 0.070 |
Why?
| | Amlodipine | 1 | 2005 | 8 | 0.060 |
Why?
| | Contrast Media | 1 | 2008 | 343 | 0.060 |
Why?
| | Lisinopril | 1 | 2005 | 13 | 0.060 |
Why?
| | Electrocardiography | 1 | 2008 | 562 | 0.060 |
Why?
| | Patient Selection | 1 | 2008 | 641 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 904 | 0.060 |
Why?
| | Southeastern United States | 2 | 2001 | 30 | 0.050 |
Why?
| | Antihypertensive Agents | 1 | 2005 | 429 | 0.050 |
Why?
| | Guidelines as Topic | 1 | 2003 | 244 | 0.050 |
Why?
| | Interprofessional Relations | 1 | 2003 | 249 | 0.050 |
Why?
| | Adolescent Psychiatry | 1 | 2001 | 12 | 0.050 |
Why?
| | Hypoglycemia | 1 | 2005 | 386 | 0.050 |
Why?
| | Adolescent Health Services | 1 | 2001 | 68 | 0.040 |
Why?
| | Middle Aged | 7 | 2022 | 26746 | 0.040 |
Why?
| | Humans | 11 | 2022 | 114716 | 0.040 |
Why?
| | Mental Health Services | 1 | 2001 | 316 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2008 | 3031 | 0.030 |
Why?
| | Female | 9 | 2022 | 59486 | 0.030 |
Why?
| | Health Surveys | 1 | 1998 | 443 | 0.030 |
Why?
| | Calcium | 1 | 2022 | 1103 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2003 | 4622 | 0.030 |
Why?
| | Diagnosis, Differential | 2 | 2009 | 1340 | 0.030 |
Why?
| | Internship and Residency | 1 | 2003 | 932 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1690 | 0.030 |
Why?
| | Medically Uninsured | 1 | 1995 | 122 | 0.030 |
Why?
| | Male | 8 | 2012 | 55558 | 0.030 |
Why?
| | Risk Factors | 2 | 2022 | 8626 | 0.030 |
Why?
| | Myocardial Infarction | 2 | 2012 | 927 | 0.030 |
Why?
| | Mental Disorders | 1 | 2001 | 889 | 0.030 |
Why?
| | Angina Pectoris | 1 | 2012 | 63 | 0.030 |
Why?
| | Myocardial Revascularization | 1 | 2012 | 67 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2005 | 2096 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 2012 | 115 | 0.020 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 179 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2012 | 1080 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2009 | 258 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 1998 | 4406 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2009 | 309 | 0.020 |
Why?
| | Aged | 4 | 2012 | 19079 | 0.020 |
Why?
| | Gadolinium DTPA | 1 | 2008 | 47 | 0.020 |
Why?
| | California | 1 | 2009 | 356 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 2008 | 168 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 445 | 0.020 |
Why?
| | Angina, Unstable | 1 | 2008 | 72 | 0.020 |
Why?
| | Image Enhancement | 1 | 2008 | 158 | 0.020 |
Why?
| | Physarum | 1 | 1986 | 4 | 0.020 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2008 | 172 | 0.020 |
Why?
| | Cell Nucleolus | 1 | 1986 | 17 | 0.020 |
Why?
| | Odds Ratio | 1 | 2009 | 954 | 0.020 |
Why?
| | Acute Disease | 1 | 2009 | 912 | 0.020 |
Why?
| | Adolescent | 3 | 2001 | 17808 | 0.020 |
Why?
| | Fungal Proteins | 1 | 1986 | 119 | 0.020 |
Why?
| | Ribonucleoproteins | 1 | 1986 | 85 | 0.020 |
Why?
| | Child | 3 | 2001 | 18352 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2005 | 4420 | 0.010 |
Why?
| | Risk Assessment | 1 | 2012 | 2973 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 4899 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1986 | 592 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2005 | 1662 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2008 | 2538 | 0.010 |
Why?
| | Animals | 2 | 1998 | 31761 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2001 | 482 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 6124 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 2009 | 1812 | 0.010 |
Why?
| | Population Surveillance | 1 | 2001 | 392 | 0.010 |
Why?
| | Prospective Studies | 1 | 2009 | 6216 | 0.010 |
Why?
| | Schools | 1 | 2001 | 399 | 0.010 |
Why?
| | Adult | 3 | 2008 | 30543 | 0.010 |
Why?
| | Blood Glucose | 1 | 2005 | 1821 | 0.010 |
Why?
| | Sex Factors | 1 | 2001 | 1717 | 0.010 |
Why?
| | Aid to Families with Dependent Children | 1 | 1995 | 4 | 0.010 |
Why?
| | National Health Insurance, United States | 1 | 1995 | 5 | 0.010 |
Why?
| | Cost Control | 1 | 1995 | 38 | 0.010 |
Why?
| | State Health Plans | 1 | 1995 | 32 | 0.010 |
Why?
| | Incidence | 1 | 2001 | 2312 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2001 | 2382 | 0.010 |
Why?
| | Mass Screening | 1 | 2001 | 1003 | 0.010 |
Why?
| | Managed Care Programs | 1 | 1995 | 133 | 0.010 |
Why?
| | Health Care Reform | 1 | 1995 | 92 | 0.010 |
Why?
| | Age Factors | 1 | 2001 | 2889 | 0.010 |
Why?
| | Forecasting | 1 | 1995 | 331 | 0.010 |
Why?
| | Data Collection | 1 | 1995 | 622 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2005 | 9089 | 0.010 |
Why?
| | Medicaid | 1 | 1995 | 407 | 0.010 |
Why?
| | Medicare | 1 | 1995 | 665 | 0.010 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1986 | 18 | 0.000 |
Why?
| | Cross Reactions | 1 | 1986 | 117 | 0.000 |
Why?
| | RNA, Fungal | 1 | 1986 | 66 | 0.000 |
Why?
| | Antibody Specificity | 1 | 1986 | 176 | 0.000 |
Why?
| | Molecular Weight | 1 | 1986 | 331 | 0.000 |
Why?
| | Epitopes | 1 | 1986 | 435 | 0.000 |
Why?
| | Antibodies, Monoclonal | 1 | 1986 | 1270 | 0.000 |
Why?
| | Liver | 1 | 1986 | 1631 | 0.000 |
Why?
| | United States | 1 | 1995 | 12176 | 0.000 |
Why?
| | Rats | 1 | 1986 | 4943 | 0.000 |
Why?
|
|
Moloo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|